accurate medication with diagnosis
1. Biomarker diagnosis of cancer and target therapy
Lung cancer EGFR mutation detection (tissue, liquid biopsy)
Colorectal cancer All RAS mutation detection (tissue)
Breast cancer PIK3CA mutation detection (tissue)
Comprehensive detection of gene fusion target drug group (organization)
Comprehensive detection of blood cancer gene fusion and mutation
Sarcoma genome testing
Highly sensitive detection of minimal residual disease in tumor liquid biopsy
2. Antibiotic resistance diagnosis
NG-Test MCR-1: NG-Test MCR-1 is a qualitative rapid immunoassay for the detection of the MCR-1 enzyme in a bacterial colony obtained from culture.
NG-Test CARBA 5: an in vitro rapid and visual multiplex immunochromatographic assay for the qualitative detection and differentiation of five common carbapenemases (KPC, OXA-48-like, VIM, IMP and NDM) from carbapenem non-susceptible pure bacterial colonies.
NG-Test CTX-M MULTI: NG-Test CTX-M MULTI is a qualitative rapid immunoassay for the detection of CTX-M groups 1, 2, 8, 9 and 25 in a bacterial colony obtained from culture.